Search results

ANSTO completed an international overnight dash for nuclear medicine earlier this week, chartering three planes to get potentially life-saving children’s cancer treatments from Japan to hospitals across Australia.

Commitment to undertake health research.

Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.

International research led by Monash University and the Peter Doherty Institute for Infection and Immunity has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.

Biochemical and structural studies to elucidate protein interactions of the new compounds and target molecules included X-ray diffraction at the Australian Synchrotron.

Australian-first detector to accelerate cancer research unveiled.

ANSTO offers reliable and traceable calibration services for radiation survey meters, contamination monitors and electronic personal dosimeters.

A desire to give people around the world greater access to the benefits of nuclear medicine is behind Robert Raposio and his research into producing radioisotopes in more efficient, cheaper and sustainable ways.

The Minerals consultancy group at ANSTO has expertise in chemical engineering, metallurgy, mineralogy, chemistry, geology, and radiation safety. We can support our client's project by providing process development services, technical review, and research.

Congress marks watershed moment for nuclear medicine and ANSTO

ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.

ANSTO has been licensed as the Australian manufacturing partner of an innovative, non-invasive treatment for non-melanoma skin cancer (NMSC).